DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied B...(ng in more than 70 countries DuPont offe...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
Date:1/14/2008
ng in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.
(Bios and photos of Nicholas Fanandakis and William Harvey are available at http://www2.dupont.com/Our_Company/en_US/executives/index.html )
'/>"/>
| SOURCE DuPont Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. KGI Names Kerry Howell Vice President for Advancement
9. Vical Names Andrew de Guttadauro Vice President, Corporate Development
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
Breaking Biology Technology:Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4
[0] Martek Signs Sole-Source Supply Agreement with Fonterra[0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert [0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain[0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products
Other Biology Technology:Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 2Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 3Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 4Could Database Software Help Cure Alzheimer's and Save the Earth? 2Could Database Software Help Cure Alzheimer's and Save the Earth? 3/C O R R E C T I O N -- Rosetta Genomics Ltd/ 2/C O R R E C T I O N -- Rosetta Genomics Ltd/ 3/C O R R E C T I O N -- Rosetta Genomics Ltd/ 4/C O R R E C T I O N -- Rosetta Genomics Ltd/ 5/C O R R E C T I O N -- Rosetta Genomics Ltd/ 6
Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2University of California, San Francisco, researcher receives ASBMB-Merck Award 2New engineering institute to modify, develop technology for the global poor 2New engineering institute to modify, develop technology for the global poor 3ICBS to focus on pharmaceutical and environmental markets 53717 1ICBS to focus on pharmaceutical and environmental markets 53717 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 3DEET in Bug Spray Tied to Neural Damage in Mice 53713 1DEET in Bug Spray Tied to Neural Damage in Mice 53713 2DEET in Bug Spray Tied to Neural Damage in Mice 53713 3
Other Biology News:Scientists stop autoimmune disease without shutting off immune system 2Adult stem cells are touchy-feely, need environmental clues 2First 'encyclopedia' of nuclear receptors reveals organisms' focus on sex, food 2First 'encyclopedia' of nuclear receptors reveals organisms' focus on sex, food 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |